Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2012; 4(02): 101-111
DOI: 10.4103/0974-2727.105592
How I do it?

Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 1: Microscopic Observation Drug Susceptibility Assay v2.4.12

Sarman Singh
Department of Laboratory Medicine, Division of Clinical Microbiology, All India Institute of Medical Sciences, New Delhi, India
Department of Culture and Drug Susceptibility Testing Subgroup, New Diagnostic Working Group, STOP TB Partnership, Geneva, Switzerland
,
Parveen Kumar
Department of Laboratory Medicine, Division of Clinical Microbiology, All India Institute of Medical Sciences, New Delhi, India
,
Shreya Sharma
Department of Laboratory Medicine, Division of Clinical Microbiology, All India Institute of Medical Sciences, New Delhi, India
,
Francis Mumbowa
Department of Medical Microbiology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda
Department of Culture and Drug Susceptibility Testing Subgroup, New Diagnostic Working Group, STOP TB Partnership, Geneva, Switzerland
,
Anandi Martin
Department of Biochemistry and Microbiology, Ghent University, Belgium
Department of Culture and Drug Susceptibility Testing Subgroup, New Diagnostic Working Group, STOP TB Partnership, Geneva, Switzerland
,
Nicolas Durier
Department of Culture and Drug Susceptibility Testing Subgroup, New Diagnostic Working Group, STOP TB Partnership, Geneva, Switzerland
› Author Affiliations Source of Support: Culture and drug susceptibility testing subgroup, Stop-TB Partnership, WHO & FIND, Geneva, Switzerland.
› Further Information
Also available at
  PDF Download Permissions and Reprints

ABSTRACT

Multidrug-resistant tuberculosis is an increasing public health concern in many parts of the world, especially in low-income countries, where most cases occur. Traditional mycobacteria culture and drug susceptibility testing (DST) is either time-consuming or expensive and for that reason uptake of these technologies has remained limited in many resource-constrained settings. However, several non-commercial culture and DST methods that do not require sophisticated infrastructure and techniques have been developed. One such method is the microscopic observation drug susceptibility assay (MODS). In this method microcolonies that form in the liquid culture medium after specimen inoculation to drug-free and drug-containing micro-wells are detected by visual observation with a simple inverted microscope. The identification and drug susceptibility results can be obtained in 7-15 days. This standard operating procedure document has been developed through the culture and DST subgroup of the STOP TB Partnership, New Diagnostic Working Group. It is intended for laboratories that would want to use or already using this rapid non-commercial method for culture identification and DST of Mycobacterium tuberculosis, notably in resource-constraint settings in Asia and Africa.

Keywords

Tuberculosis - rapid - drug susceptibility testing - Stop- TB - Training


Publication History

Article published online:
09 May 2020

© 2012.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • FURTHER READING

  • 1 Caviedes L, Moore DA. Introducing MODS: A low-cost, low-tech tool for high-performance detection of tuberculosis and multidrug resistant tuberculosis. Indian J Med Microbiol 2007;25:87-8.
  • 2 Kent PT, Kubica GP. Public Health Mycobacteriology: A Guide for the Level III Laboratory. Washington, DC, Centres for Disease Control and Prevention, Atlanta US Government Printing Office; 1985. p. 207.
  • 3 Coronel J, Roper M, Caviedes L, Moore D. MODS. A User Guide. Microscopic-Observation Drug-Susceptibility Assay, 2008. Available from: http://www.modsperu.org/MODS_user_guidepdf. V12.213012012. [Last Accessed on 2012 Feb 28].
  • 4 Moore DA. Future prospects for the MODS assay in multidrug-resistant tuberculosis diagnosis. Future Microbiol 2007;2:97-101.
  • 5 World Health Organization. Noncommercial culture and drug susceptibility testing methods for screening of patients at risk of multi drug resistant tuberculosis: Policy statement; July, 2010. Available from: http://www.who.int/tb/dots/laboratory/whopolicy_noncommercialculture_and_dstmethods_july10.pdf. [Last accessed on 2012 Nov 10].